shuterstock-138839393

Lightspring / Shutterstock.com

27 November 2014Ranjna Mehta-Dutt and Neha Srivastava

Biologics in India: bridging the gap

Section 10(4)(ii)(D) of India’s Patents Act, 1970 mandates the disclosure of the source and geographical origin of biological material whenever it’s mentioned in a patent specification but not sufficiently described in it or made available to the public.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

China’s new policies on foreign investment in healthcare and biotech

Startup CFO’s betrayal is a lesson in preparing for the worst

How post-filing data rescued Novo Nordisk’s Ozempic patent in China

How to navigate patent term adjustment in China

Preventative IP for preventative pharma healthcare

Dexcom suffers second patent revocation at hands of UPC

Does the UPC offer a fresh take on patent validity?

Litigation implications of the USPTO’s terminal disclaimer proposal